Kromek Group (KMK) Share Price, News & Analysis

Company Overview

Kromek Group plc, together with its subsidiaries, develops, manufactures, and sells radiation detection components and devices for the medical imaging, civil nuclear, CBRNe security, and safety screening markets. The company's products provide high resolution information on material composition and structure that are used in various applications. It also offers civil nuclear radiation detection products, which include gamma radiation and neutron detectors, high-specification, high-resolution devices, components, and software for nuclear detection problems, as well as offers a range of radiation detectors that use cadmium zinc telluride (CZT) or scintillator technology for gamma-ray, x-ray, and neutron detection. In addition, the company provides medical imaging products, including CZT gamma detectors for SPECT imaging, CZT bone mineral densitometry detectors, and photon-counting spectral CT systems. Further, it offers CBRNE homeland security products and solutions for government, border control, airport and seaports, HazMat teams, ambulance crews, police, and armed forces, as well as a range of gamma spectroscopy software that enables specialized gamma-ray spectroscopy for the analysis of samples. Additionally, the company provides CZT imaging development platforms, such as the DMatrix and the EV3500 scalable x-ray CZT linear array for laboratory and research imaging; and engages in the scientific research and development activities. It sells its products through distributors, OEMs, and direct sales. The company has operations in the United Kingdom, North America, Asia, Europe, Australasia, and Africa. Kromek Group plc was incorporated in 2013 and is headquartered in Sedgefield, the United Kingdom.

Key Stats

• Today's Range: 5.91 to 6.10
• 50-Day Range: 5.40 to 7.80
• 52-Week Range: 3.82 to 8.50
• Volume: 830,069 shs
• Average Volume: 1.11 million shs
• Market Capitalization: £37.98 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

KMK Stock Analysis - Frequently Asked Questions

How have KMK shares performed this year?

Kromek Group's stock was trading at GBX 4.80 at the beginning of the year. Since then, KMK stock has increased by 23.3% and is now trading at GBX 5.92.
View the best growth stocks for 2024 here.

How were Kromek Group's earnings last quarter?

Kromek Group plc (LON:KMK) posted its quarterly earnings data on Wednesday, December, 11th. The company reported ($0.70) earnings per share for the quarter. Kromek Group had a negative trailing twelve-month return on equity of 8.92% and a negative net margin of 23.25%.

How do I buy shares of Kromek Group?

Shares of KMK stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Kromek Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Kromek Group investors own include Eden Research (EDEN), 4D pharma (DDDD), IQE (IQE), Tullow Oil (TLW), 88 Energy (88E), Active Energy Group (AEG) and AFC Energy (AFC).

Company Calendar

• Last Earnings: 12/11/2019
• Today: 11/21/2024

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Computer and Technology
• Industry: Scientific & Technical Instruments
• Sub-Industry: N/A
• Current Symbol: LON:KMK
• CUSIP: N/A
• CIK: N/A
• Web: www.kromek.com
• Phone: +44-1740-626060
• Fax: N/A
• Employees: 166
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX (0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £-4,100,000.00
• Net Margins: -23.25%
• Pretax Margin: N/A
• Return on Equity: -8.92%
• Return on Assets: -3.20%

Debt

• Debt-to-Equity Ratio: 28.33
• Current Ratio: 2.06
• Quick Ratio: 0.82

Sales & Book Value

• Annual Sales: £17.62 million
• Price / Sales: 2.18
• Cash Flow: GBX 0.71 per share
• Price / Cash Flow: 8.45
• Book Value: GBX 8 per share
• Price / Book: 0.75

Miscellaneous

• Outstanding Shares: 641,550,000
• Free Float: N/A
• Market Cap: £38.49 million
• Optionable: Not Optionable
• Beta: 0.94